Bright Minds Biosciences (DRUG) Change in Accured Expenses (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Change in Accured Expenses came in at $1.7 million in Q1 2026, up 1285.89% YoY from $119422.9 in Q1 2025, and up 451.01% on a QoQ basis from -$471518.7 in Q4 2025.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Change in Accured Expenses data on file, last reported at $1.7 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Bright Minds Biosciences | 449.62 Mn | 227.08 Mn | - | -919,758.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -919,758.31 |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -471,518.65 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | -24,114.58 |
| Mar 31, 2025 | 119,422.91 |
| Dec 31, 2024 | -43,267.35 |
| Sep 30, 2024 | 208,690.78 |
| Jun 30, 2024 | -472,640.69 |
| Mar 31, 2024 | 8,503.13 |
| Dec 31, 2023 | 435,058.05 |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | 918,296.26 |
| Mar 31, 2023 | 350,628.65 |
| Dec 31, 2022 | -697,200.19 |
| Sep 30, 2022 | 393,140.70 |
| Jun 30, 2022 | -87,605.36 |
| Mar 31, 2022 | 170,499.06 |
| Dec 31, 2021 | 118,188.83 |
| Sep 30, 2021 | 258,511.12 |